Gregory Odle Sells 8,433 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory Odle sold 8,433 shares of OrthoPediatrics stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $145,469.25. Following the completion of the transaction, the insider directly owned 187,735 shares in the company, valued at $3,238,428.75. This represents a 4.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS traded up $0.10 during midday trading on Tuesday, reaching $17.21. The company’s stock had a trading volume of 197,133 shares, compared to its average volume of 152,452. OrthoPediatrics Corp. has a one year low of $15.28 and a one year high of $26.40. The company has a market cap of $435.07 million, a price-to-earnings ratio of -10.18 and a beta of 1.07. The company has a 50 day moving average price of $17.74 and a 200 day moving average price of $17.97. The company has a current ratio of 5.55, a quick ratio of 2.65 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Thursday, February 26th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.11. The firm had revenue of $61.61 million during the quarter, compared to analysts’ expectations of $61.27 million. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. On average, equities research analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. boosted its position in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after acquiring an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after purchasing an additional 2,561 shares in the last quarter. Caption Management LLC acquired a new position in OrthoPediatrics in the 3rd quarter valued at approximately $54,000. BNP Paribas Financial Markets lifted its position in OrthoPediatrics by 60.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares in the last quarter. Finally, State of Wyoming lifted its position in OrthoPediatrics by 189.7% in the 4th quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after buying an additional 4,467 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. BTIG Research lifted their target price on OrthoPediatrics from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, February 27th. Truist Financial increased their price target on OrthoPediatrics from $19.00 to $20.00 and gave the company a “hold” rating in a research report on Monday, March 2nd. Wall Street Zen raised OrthoPediatrics from a “sell” rating to a “hold” rating in a research note on Saturday, March 7th. Needham & Company LLC boosted their price objective on OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 27th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.67.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.